Insulin glargine and lixisenatide Subcutaneous and Suprep
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Suprep and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: magnesium sulfate / potassium sulfate / sodium sulfate
Brand name: Suprep Bowel Prep Kit
Synonyms: Suprep Bowel Prep Kit, Suprep Bowel Prep
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Suprep Bowel Prep
- Insulin glargine and lixisenatide Subcutaneous-Suprep Bowel Prep Kit
- Insulin glargine and lixisenatide Subcutaneous-Supress A
- Insulin glargine and lixisenatide Subcutaneous-Supress A Pediatric
- Insulin glargine and lixisenatide Subcutaneous-Supress-PE
- Insulin glargine and lixisenatide Subcutaneous-Sure Result DSS Premium Pak
- Suprep-Insulin glargine, recombinant Subcutaneous
- Suprep-Insulin glulisine
- Suprep-Insulin Glulisine (Cartridges and Pens)
- Suprep-Insulin Glulisine (Vials)
- Suprep-Insulin glulisine Subcutaneous
- Suprep-Insulin human inhaled Inhalation